Document Detail


Diffuse diabetic macular oedema treated by intravitreal triamcinolone acetonide: a comparative, non-randomised study.
MedLine Citation:
PMID:  15722313     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
AIM: To report on visual outcome of patients receiving an intravitreal injection of triamcinolone acetonide for treatment of diffuse diabetic macular oedema.
METHODS: Prospective, comparative, non-randomised clinical interventional study included 136 patients with diffuse diabetic macular oedema. Patients of the study group (97 eyes) received an intravitreal injection of 20-25 mg of triamcinolone acetonide and no other retinal treatment. Patients of the control group (69 eyes) received focal or panretinal laser treatment if indicated. Mean (standard deviation) follow up was 8.4 (SD 6.0) months (range 1.03-25.2 months).
RESULTS: Visual acuity (VA) increased significantly (p<0.001) in the study group with 66 (68%) eyes gaining in VA by at least two Snellen lines. In the control group, VA did not change significantly during the first 4 months of follow up, and decreased significantly (p<0.001) towards the end of the follow up. Difference in change of best VA was significant (p<0.001) between both groups. Correspondingly, the number of patients with VA improvement of two or more Snellen lines and visual loss of two or more Snellen lines, respectively, was significantly (p<0.001) higher and lower, respectively, in the study group.
CONCLUSIONS: Intravitreal triamcinolone acetonide can temporarily increase VA in some patients with diffuse diabetic macular oedema.
Authors:
J B Jonas; I Akkoyun; I Kreissig; R F Degenring
Related Documents :
17397743 - Successful treatment of cystoid macular edema with valdecoxib.
18502643 - Blindness following pituitary apoplexy: timing of surgery and neuro-ophthalmic outcome.
23142603 - Normal values of pharyngeal and esophageal 24-hour ph-impedance in individuals on and o...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article    
Journal Detail:
Title:  The British journal of ophthalmology     Volume:  89     ISSN:  0007-1161     ISO Abbreviation:  Br J Ophthalmol     Publication Date:  2005 Mar 
Date Detail:
Created Date:  2005-02-21     Completed Date:  2005-05-09     Revised Date:  2013-06-09    
Medline Journal Info:
Nlm Unique ID:  0421041     Medline TA:  Br J Ophthalmol     Country:  England    
Other Details:
Languages:  eng     Pagination:  321-6     Citation Subset:  IM    
Affiliation:
Department of Ophthalmology, Faculty of Clinical Medicine Mannheim of the University of Heidelberg, Heidelberg, Germany. Jost.Jonas@ma.augen.uni-heidelberg.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Anti-Inflammatory Agents / administration & dosage*,  therapeutic use
Chi-Square Distribution
Diabetes Mellitus / drug therapy*,  physiopathology,  surgery
Female
Follow-Up Studies
Humans
Injections
Laser Therapy
Macular Degeneration / drug therapy*,  physiopathology,  surgery
Male
Middle Aged
Prospective Studies
Statistics, Nonparametric
Triamcinolone Acetonide / administration & dosage*,  therapeutic use
Visual Acuity
Vitreous Body
Chemical
Reg. No./Substance:
0/Anti-Inflammatory Agents; 76-25-5/Triamcinolone Acetonide
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Optical coherence tomography in photodynamic therapy for subfoveal choroidal neovascularisation seco...
Next Document:  Late onset of rhegmatogenous retinal detachments after successful posterior segment intraocular fore...